Home » Topics » BioWorld Science

BioWorld Science
RSS

Antifungal agents prepared at Pola

Jan. 5, 1998

NOS inhibitors prepared at Ono

Jan. 5, 1998

Antiamnesic compounds described by Gedeon Richter

Jan. 5, 1998

Structurally distinct vitamin D analogues from Leo

Jan. 5, 1998

Company Profile: Teva

Jan. 5, 1998

QLT PhotoTherapeutics: Q3 1997 highlights

Jan. 5, 1998

Anti-GnRH immunogens disclosed by Aphton

Jan. 5, 1998

Native calcitonin mimetics from ZymoGenetics

Jan. 5, 1998

Polypeptide-chelating agent complexes reported by Novartis

Jan. 5, 1998

COX-2 inhibitors reported by UPSA

Jan. 5, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...